Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.

By G. Lyman, A. Khorana, N. Kuderer, Agnes Y. Y. Lee, J. Arcelus, E. Balaban, J. Clarke, C. Flowers, C. Francis, L. Gates and 8 more. Journal of Clinical Oncology, 2013

833 citations recorded by the source corpus.

Subfields: Internal Medicine, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/4ddfba6fa7fbfa0174c25345050d8e3dbe69b263

Citations in the corpus

• Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). (2018, neutral): “9 Currently receiving cancer treatment§ 142 (70) 140 (69) Chemotherapy 120 (85) 113 (81) Radiotherapy 10 (7) 6 (4) Targeted therapy 22 (15) 21 (15) Endocrine therapy 15 (11) 15 (11) Primary tumor type Bladder 4 (2) 10 (5) Brain 2 (1) 1 (1) Breast 20 (10) 20 (10) Cancer unknown primary 3 (2) 3 (1) Ch”